Thomas F Gajewski
Thomas F Gajewski
Dirección de correo verificada de
TítuloCitado porAño
Innate and adaptive immune cells in the tumor microenvironment
TF Gajewski, H Schreiber, YX Fu
Nature immunology 14 (10), 1014, 2013
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
A Sivan, L Corrales, N Hubert, JB Williams, K Aquino-Michaels, ZM Earley, ...
Science 350 (6264), 1084-1089, 2015
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
TF Gajewski, FW Fitch
The Journal of Immunology 140 (12), 4245-4252, 1988
Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells
S Spranger, RM Spaapen, Y Zha, J Williams, Y Meng, TT Ha, TF Gajewski
Science translational medicine 5 (200), 200ra116-200ra116, 2013
Helper T cell differentiation is controlled by the cell cycle
JJ Bird, DR Brown, AC Mullen, NH Moskowitz, MA Mahowald, JR Sider, ...
Immunity 9 (2), 229-237, 1998
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
S Spranger, R Bao, TF Gajewski
Nature 523 (7559), 231, 2015
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells
C Blank, I Brown, AC Peterson, M Spiotto, Y Iwai, T Honjo, TF Gajewski
Cancer research 64 (3), 1140-1145, 2004
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
MB Fuertes, AK Kacha, J Kline, SR Woo, DM Kranz, KM Murphy, ...
Journal of Experimental Medicine 208 (10), 2005-2016, 2011
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
H Harlin, Y Meng, AC Peterson, Y Zha, M Tretiakova, C Slingluff, ...
Cancer research 69 (7), 3077-3085, 2009
STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors
L Deng, H Liang, M Xu, X Yang, B Burnette, A Arina, XD Li, H Mauceri, ...
Immunity 41 (5), 843-852, 2014
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10 (1), 205, 2012
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors
SR Woo, MB Fuertes, L Corrales, S Spranger, MJ Furdyna, MYK Leung, ...
Immunity 41 (5), 830-842, 2014
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
SJ O'day, M Maio, V Chiarion-Sileni, TF Gajewski, H Pehamberger, ...
Annals of Oncology 21 (8), 1712-1717, 2010
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
C Blank, TF Gajewski, A Mackensen
Cancer Immunology, Immunotherapy 54 (4), 307-314, 2005
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
V Matson, J Fessler, R Bao, T Chongsuwat, Y Zha, ML Alegre, JJ Luke, ...
Science 359 (6371), 104-108, 2018
A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ...
European journal of immunology 24 (12), 3038-3043, 1994
Blocked Ras activation in anergic CD4+ T cells
PE Fields, TF Gajewski, FW Fitch
Science 271 (5253), 1276-1278, 1996
Differential regulation of murine T lymphocyte subsets
FW Fitch, MD McKisic, DW Lancki, TF Gajewski
Annual review of immunology 11 (1), 29-48, 1993
Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.
TF Gajewski, M Pinnas, T Wong, FW Fitch
The Journal of Immunology 146 (6), 1750-1758, 1991
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20